CME Group Inc. reported record financial results for the full year 2024, achieving total revenue of $6.1 billion and operating income of $3.9 billion. The company's net income reached $3.5 billion, with diluted earnings per common share of $9.67. On an adjusted basis, net income was $3.7 billion, and diluted earnings per share were $10.26, marking the best year ever for CME Group.
This record performance was driven by record annual average daily volume (ADV) across all asset classes, including new records in interest rates (U.S. Treasury and SOFR complexes), agricultural, foreign exchange, and metals markets. Fourth-quarter 2024 ADV was 25.5 million contracts, in line with Q4 2023, including non-U.S. ADV of 7.6 million contracts, up 5% year-over-year.
Clearing and transaction fees revenue for full-year 2024 totaled $4.988 billion, with Q4 2024 contributing $1.2 billion. Market data revenue for the year reached $710.2 million, with $182 million in Q4. The company declared dividends totaling $3.8 billion in 2024, including an annual variable dividend of $2.1 billion, and increased its first-quarter 2025 dividend by 9% to $1.25 per share. These results demonstrate CME Group's operational excellence and commitment to shareholder returns.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.